A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Lay Description
Category
- Heart, Vascular and Blood
- IRB Number
- 20220092HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Johnnie Jones
210-450-7277
jonesj21@uthscsa.edu
Lorannys Sanchez Tamarez
210-450-3937
sancheztamar@uthscsa.edu
Principal Investigator
Carolina Solis-Herrera